Clinical Trial

Global Myofascial Treatment With Shockwave for Non-Specific Low Back Pain

Completed
View on ClinicalTrials.gov →
Summary
This study aims to examine the effects of shockwave therapy on myofascial tissue (muscles, fascia, and connective tissue), focusing on pain reduction and improvement of mobility. The results will be compared with those of conventional manual physiotherapy. Myofascial tissue can be a source of back pain, as it may contain painful spots known as myofascial trigger points (MTrPs). Shockwave therapy can stimulate these trigger points, potentially leading to muscle and fascia relaxation and, as a result, a decrease in pain. The study investigates how focused shockwave trigger point therapy influences back function and pain perception compared to traditional physiotherapeutic treatment. Participation is voluntary. The examinations will only be carried out if you provide written informed consent. You may refuse participation or withdraw your consent at any time without any disadvantages.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-02.
Trial Details
NCT Number NCT07692347
Lead Sponsor University Hospital Muenster
Conditions Low Back Pain
Enrollment 44 participants
Start Date 2022-08-01
Primary Completion 2022-12-31 (estimated)
Study Completion 2026-04-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-16